newsfilter
← Latest News
GlobeNewswire·

Pasithea Therapeutics Confirms Previous Creation of Independent Special Committee of its Board of Directors

PALO ALTO, Calif. and MIAMI, June 30, 2023 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a biotechnology company focused on the discovery, research, and development of